G & L Research

08/01/2026

We’re looking for people who experience constipation to join a research study. If you qualify, you’ll be compensated for your time and contribute to future breakthroughs.
trialpartners.co/s/c-0oM8y7f9

07/31/2026

🫀 Survived a heart attack or stroke?
💊 Taking a statin — or unable to tolerate statins — and LDL still high?

You take your medication — but LDL doesn't always respond to statins alone. A cardiovascular research study at G & L Research, Foley, Alabama is now enrolling.

You may qualify if you:
✅ Had a heart attack, stroke, or PAD in the last 12 months
✅ Currently taking a stable statin dose, or unable to tolerate statins
✅ LDL still elevated despite treatment
✅ No revascularization planned in the next 3 months
✅ Age 18 or older
✅ Based in Alabama and able to travel to Foley for study visits

Study-related care at no cost. Compensation available for time and travel. Reviewed and approved by an Institutional Review Board.

☎️ Call 251-943-2980 to see if you qualify.

07/31/2026

🫀 Survived a heart attack or stroke?
💊 Taking a statin — or unable to tolerate statins — and LDL still high?

You take your medication — but LDL doesn't always respond to statins alone. A cardiovascular research study at G & L Research, Foley, Alabama is now enrolling.

You may qualify if you:
✅ Had a heart attack, stroke, or PAD in the last 12 months
✅ Currently taking a stable statin dose, or unable to tolerate statins
✅ LDL still elevated despite treatment
✅ No revascularization planned in the next 3 months
✅ Age 18 or older
✅ Based in Alabama and able to travel to Foley for study visits

Study-related care at no cost. Compensation available for time and travel. Reviewed and approved by an Institutional Review Board.

See if you qualify👇

✅ Compensation available for time and travel

07/25/2026

Is gout impacting your daily life?

Explore new gout clinical trials near you through the JEWEL Program. Adults with gout or tophaceous gout can learn about the RUBY and TOPAZ studies near them.

07/19/2026

Location: Foley, AL

07/17/2026

We're incredibly proud to have played a role in helping bring this drug to market. It's an honor to have contributed to the research that helped make this milestone possible.

NEW OPTION: The FDA has approved the first-ever oral PCSK9 drug for millions of Americans battling high cholesterol.

Lipfendra, made by Merck, reduced LDL cholesterol by 56% to 60% when combined with statins in clinical trials — roughly double the impact of statins alone.

Until now, PCSK9 inhibitors were only available as injections, a factor experts say contributed to their underuse.

👉 Full story here: https://www.foxnews.com/health/game-changing-cholesterol-pill-wins-fda-approval-cutting-ldl-nearly-60

07/07/2026

Still at risk even though you take cholesterol medication? A research study in Alabama is now enrolling.

✅ Study-related care, lab work, and heart monitoring provided at no cost
✅ Compensation available for time and travel
✅ Reviewed and approved by the Advarra Institutional Review Board

Find out if you qualify through a quick, 3-minute check.

IRB approved by Advarra.

07/01/2026

🇺🇸 Holiday Closure Notice 🇺🇸

In observance of Independence Day, we will be closed Friday, July 3.

We hope you have a safe and happy holiday celebrating with family and friends! ❤️🤍💙

07/01/2026

🧻Struggling with chronic constipation? You may qualify for a clinical trial investigating a potential new treatment.

Call G & L Research @ 251-943-2980 to see if you qualify.

06/19/2026